Pharmacotherapy for allergic contact dermatitis.
Allergic contact dermatitis is a highly prevalent, potentially chronic disease, with a significant economic and quality of life impact. Culprit causal allergen(s) can be identified though patch testing, the 'gold-standard' diagnostic method. For most people, identification and subsequent avoidance of their clinically relevant allergens will results in resolution of the dermatitis. However, when an avoidance regimen is not possible, or an allergen is not identified, patients potentially require symptomatic and immunosuppressive therapy to diminish the manifestations of their disease. This article reviews a therapeutic approach to allergic contact dermatitis.
Jacob
Sharon E
SE
University of Miami, Leonard M. Miller School of Medicine, Department of Dermatology and Cutaneous Surgery, Florida 33124, USA. sjacob@med.miami.edu
Castanedo-Tardan
Mari Paz
MP
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000485:Allergens / Q000009:adverse effects; D000818:Animals; D000529:Complementary Therapies; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000628:therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010328:Patch Tests
D000305:Adrenal Cortex Hormones; D000485:Allergens; D006634:Histamine H1 Antagonists; D007155:Immunologic Factors